EVOLVING CONCEPTS IN PCOS: DIAGNOSTIC INNOVATIONS AND NOVEL THERAPEUTIC STRATEGIES

Read full text Summarise with VIRAT
Authors: 1Sharma Upasana D., 2*Thaker Kwisha, 3Sathwara Maitri, 4Sathwara Setu, 5Barot Hinal
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Polycystic Ovary Syndrome (PCOS) is far more than a reproductive disorder; it is a complex endocrine and metabolic challenge affecting up to 13% of women worldwide. While traditionally viewed through the lens of fertility, modern clinical understanding now links PCOS to deep-rooted issues like insulin resistance, chronic inflammation, and emerging evidence of gut dysbiosis. This article describes the transition from "symptom management" to "precision medicine.” The article highlights how advanced diagnostic tools—such as high-sensitivity hormonal assays and AMH testing—are providing earlier, more accurate interventions. Furthermore, the shift in the therapeutic landscape has been examined, where traditional treatments are being bolstered by novel agents like GLP-1 receptor agonists and SGLT2 inhibitors. By integrating nutraceuticals and lifestyle-focused care, the future of PCOS management lies in personalized, long-term metabolic protection rather than a one-size-fits-all approach.

Fields of Study & Subjects

Ovarian function and disorders Diabetes Cardiovascular Risks and Lipoproteins Endometriosis Research and Treatment

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
1 April 2026
Language
EN